Formula: | C21H15F2N3O3S |
Molecular Weight: | 427.43 |
Rotatable Bond Donors: | 5 |
clogP: | 3.38 |
Topological Polar Surface Area: | 80.54 |
Lipinski's RO5: | MW: 427.43 HBA: 6 HBD: 1 RB: 5 LogP: 3.38 |
Rule of Three: | MW: 427.43 HBA: 6 HBD: 1 RB: 5 LogP: 3.38 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC95920765 | 1.0 | ZINC95920765 RDKit 3D 30 33 0 0 0 0 0 0 0 0999 V2000 3.2272 1.6082 2.8070 O 0 0 0 0 0 0 0 0 0 0 0 0 3.2663 0.9965 1.7445 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1921 0.8430 0.9081 N 0 0 0 0 0 0 0 0 0 0 0 0 0.9386 1.4442 1.2690 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1529 1.0034 0.3528 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3884 1.6916 -0.8391 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4065 1.2816 -1.6949 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1801 0.1821 -1.3418 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.4771 -0.3371 -2.4052 S 0 0 0 0 0 0 0 0 0 0 0 0 -3.0908 -1.6443 -2.8971 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.7668 0.7476 -3.3216 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.9282 -0.5369 -1.4347 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.5809 -1.7648 -1.4234 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.7300 -1.8968 -0.6517 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.3703 -3.0733 -0.6238 F 0 0 0 0 0 0 0 0 0 0 0 0 -7.2252 -0.8322 0.0954 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.5494 0.3837 0.0593 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.0119 1.4168 0.7748 F 0 0 0 0 0 0 0 0 0 0 0 0 -5.3981 0.5481 -0.7026 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.9676 -0.5092 -0.1541 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9474 -0.0931 0.6954 C 0 0 0 0 0 0 0 0 0 0 0 0 4.4958 0.3278 1.2507 C 0 0 0 0 0 0 0 0 0 0 0 0 4.6396 -0.1691 -0.1107 C 0 0 0 0 0 0 0 0 0 0 0 0 5.7764 -0.7532 -0.5331 C 0 0 0 0 0 0 0 0 0 0 0 0 6.8651 -0.9037 0.3712 C 0 0 0 0 0 0 0 0 0 0 0 0 8.0619 -1.4306 0.2234 N 0 0 0 0 0 0 0 0 0 0 0 0 8.6681 -1.3019 1.4520 C 0 0 0 0 0 0 0 0 0 0 0 0 7.8350 -0.6827 2.3581 C 0 0 0 0 0 0 0 0 0 0 0 0 6.6840 -0.4216 1.6614 N 0 0 0 0 0 0 0 0 0 0 0 0 5.5215 0.1945 2.1106 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 2 3 1 0 3 4 1 0 4 5 1 0 5 6 2 0 6 7 1 0 7 8 2 0 8 9 1 0 9 10 2 0 9 11 2 0 9 12 1 0 12 13 2 0 13 14 1 0 14 15 1 0 14 16 2 0 16 17 1 0 17 18 1 0 17 19 2 0 8 20 1 0 20 21 2 0 2 22 1 0 22 23 1 0 23 24 2 0 24 25 1 0 25 26 2 0 26 27 1 0 27 28 2 0 28 29 1 0 29 30 1 0 21 5 1 0 30 22 2 0 19 12 1 0 29 25 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |